Lecture: Shifting gears in CVD & T2DM: What is the rationale for new diabetes interventions in the course of CVD?

Media formats available:

Benefits of GLP-1RA and SGLT2-i in primary and secondary prevention of CVD in T2DM
Benefits of GLP-1RA and SGLT2-i in primary and secondary prevention of CVD in T2DM
CDMC 2018: Shifting gears in the management of diabetes and CVD
Benefits of GLP-1RA and SGLT2-i in primary and secondary prevention of CVD in T2DM
- Prof. Eduard Montanya, MD
Lecture: The GLP1 landscape - refining our understanding
Lecture: The GLP1 landscape - refining our understanding
CDMC 2018: Shifting gears in the management of diabetes and CVD
Lecture: The GLP1 landscape - refining our understanding
Lecture: Managing diabetes in daily cardiovascular practice: Potential barriers and solutions
Lecture: Managing diabetes in daily cardiovascular practice: Potential barriers and solutions
CDMC 2018: Shifting gears in the management of diabetes and CVD
Lecture: Managing diabetes in daily cardiovascular practice: Potential barriers and solutions
- Prof. Richard Hobbs, MD
Lecture: Screening for Diabetes: When is it meaningful and how should it be performed
Lecture: Screening for Diabetes: When is it meaningful and how should it be performed
CDMC 2018: Shifting gears in the management of diabetes and CVD
Lecture: Screening for Diabetes: When is it meaningful and how should it be performed
- Prof. Lars Rydén

PACE-CME